Novel treatments for rare rheumatologic disorders: analysis of the impact of 30 years of the US orphan drug act
Crossref DOI link: https://doi.org/10.1186/s13023-016-0443-x
Published Online: 2016-05-12
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Lutz, Thomas
Lampert, Anette
Hoffmann, Georg F.
Ries, Markus